SCHEMBL7883

SCHEMBL7883

c1ccn2ccnc2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL268000 1.00
Hydrochloric Acid SCHEMBL18952247 0.98 ADORA3 (0.45)
SCHEMBL31249062 0.98 ADORA3 (0.45)
SCHEMBL30084676 0.98 ADORA3 (0.45)
Hydrochloric Acid SCHEMBL30557265 0.98 ADORA3 (0.45)
SCHEMBL19463910 0.98 ADORA3 (0.45)
Water SCHEMBL6703860 0.98 ADORA3 (0.45)
Aziridine SCHEMBL12806755 0.89 ADORA3 (0.40)
SCHEMBL15110296 0.89 ALOX15 (0.60)
Perchlorate SCHEMBL10924782 0.88 ADORA3 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 11170 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4748840-A1 IMIDAZO[1,2-A]PYRIDINE TYPE IRAK DEGRADATION AGENT AND USE THEREOF TAINUORUI (TIANJIN) BIOTECHNOLOGY CO., LTD (CN) 2026-05-27 EP claimed
CN-122070278-A Bifunctional protein degradation agent containing aryl substituted heteroaryl and application thereof 标新生物医药科技(上海)有限公司 2026-05-19 CN claimed
EP-4200297-B1 IMIDAZO[1,2-A]PYRIDINE AND [1,2,4]TRIAZOLO[1,5-A]PYRIDINE DERIVATIVES AS TLR9 INHIBITORS FOR THE TREATMENT OF FIBROSIS BRISTOL MYERS SQUIBB CO (US) 2026-05-13 EP claimed
EP-4735442-A1 IMIDAZO[1,2-alpha]PYRIDINE COMPOUNDS FOR USE IN TREATING CANCER AND INFLAMMATORY DISEASES AND METHODS TO PREPARE SAID COMPOUNDS Theranib Inc. (CA) 2026-05-06 EP claimed
US-20260109699-A1 AZOLE DERIVATIVES AS SHP2 INHIBITORS IRBM S.P.A. (IT) 2026-04-23 US claimed
US-20260109697-A1 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2026-04-23 US claimed
EP-4727938-A1 BICYCLIC HETEROAROMATIC COMPOUNDS FOR TREATING NEUROLOGICAL DISORDERS Prothena Biosciences Limited (IE) 2026-04-22 EP claimed
US-20260102395-A1 INHIBITING HISTONE DEACETYLASE 6 EIKONIZO THERAPEUTICS, INC. (US) 2026-04-16 US claimed
US-12497413-B2 Compound and organic electroluminescence device containing the compound GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD (CN) 2025-12-16 US claimed
EP-4658656-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES Beone Medicines I GmbH (CH) 2025-12-10 EP claimed
US-4596872-A Imidazo[1,2-a]pyridines, and process for their preparation SCHERING A.G. (DE) 1986-06-24 US claimed
EP-0068378-B1 NOVEL IMIDAZO(1,2-A)PYRIDINES AND PYRAZINES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1986-03-05 EP claimed
EP-0091402-B1 CHROMENOAZAINDOLIZINES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN PRESSURE OR HEAT SENSITIVE RECORDING MATERIALS CIBA-GEIGY AG (CH) 1986-02-26 EP claimed
EP-0073845-B1 IMIDAZOPYRIDINE-SPIRO-PIPERIDINE COMPOUNDS Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1985-05-29 EP claimed
US-4501745-A TREATMENT OF NERVOUS SYSTEM DISORDERS SYNTHELABO (FR) 1985-02-26 US claimed
US-4492695-A ANTICONVULSANTS, SEDATIVES, TRANQUILIZERS SYNTHELABO (FR) 1985-01-08 US claimed
EP-0033094-B1 IMIDAZO(1,2-A)PYRIDINES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1984-10-10 EP claimed
US-4382938-A HYPNOSIS; TENSION; ANTICONVULSANTS; PSYCHOLOGICAL AND NERVOUS SYSTEM DISORDERS SYNTHELABO (FR) 1983-05-10 US claimed
US-4311702-A Imidazo[1,2-a]pyridines having anti-ulcer activity POLI INDUSTRIA CHIMICA S.P.A. (IT) 1982-01-19 US claimed
EP-0033094-A1 Imidazo(1,2-a)pyridines, processes for their preparation and pharmaceutical compositions containing them SCHERING CORPORATION (US) 1981-08-05 EP claimed